Nikos Afratis
Cited by
Cited by
Glycosaminoglycans: key players in cancer cell biology and treatment
N Afratis, C Gialeli, D Nikitovic, T Tsegenidis, E Karousou, AD Theocharis, ...
The FEBS journal 279 (7), 1177-1197, 2012
A guide to the composition and functions of the extracellular matrix
NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ...
The FEBS journal 288 (24), 6850-6912, 2021
Syndecans–key regulators of cell signaling and biological functions
NA Afratis, D Nikitovic, HAB Multhaupt, AD Theocharis, JR Couchman, ...
The FEBS journal 284 (1), 27-41, 2017
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans
SS Skandalis, N Afratis, G Smirlaki, D Nikitovic, AD Theocharis, ...
Matrix Biology 35, 182-193, 2014
Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells
P Bouris, SS Skandalis, Z Piperigkou, N Afratis, K Karamanou, AJ Aletras, ...
Matrix Biology 43, 42-60, 2015
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine
AD Theocharis, SS Skandalis, T Neill, HAB Multhaupt, M Hubo, H Frey, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1855 (2), 276-300, 2015
Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion
K Kouvidi, A Berdiaki, D Nikitovic, P Katonis, N Afratis, VC Hascall, ...
Journal of Biological Chemistry 286 (44), 38509-38520, 2011
Syndecans as modulators and potential pharmacological targets in cancer progression
D Barbouri, N Afratis, C Gialeli, DH Vynios, AD Theocharis, ...
Frontiers in oncology 4, 4, 2014
Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin‐like growth factor receptor in the expression of cell surface …
AI Tsonis, N Afratis, C Gialeli, MI Ellina, Z Piperigkou, SS Skandalis, ...
The FEBS journal 280 (10), 2248-2259, 2013
LOXL2 inhibition paves the way for macrophage-mediated collagen degradation in liver fibrosis
M Klepfish, T Gross, M Vugman, NA Afratis, S Havusha-Laufer, ...
Frontiers in Immunology 11, 502348, 2020
The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery
NA Afratis, M Klepfish, NK Karamanos, I Sagi
Advanced drug delivery reviews 129, 4-15, 2018
Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis
NA Afratis, M Selman, A Pardo, I Sagi
Matrix Biology 68, 167-179, 2018
IGF-IR cooperates with ERá to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
NA Afratis, P Bouris, SS Skandalis, HA Multhaupt, JR Couchman, ...
Scientific reports 7 (1), 40138, 2017
The role of heparins and nano-heparins as therapeutic tool in breast cancer
NA Afratis, K Karamanou, Z Piperigkou, DH Vynios, AD Theocharis
Glycoconjugate journal 34, 299-307, 2017
Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules
Z Piperigkou, K Karamanou, NA Afratis, P Bouris, C Gialeli, CLR Belmiro, ...
Toxicology letters 240 (1), 32-42, 2016
Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma
G Heidari-Hamedani, RR Vivès, A Seffouh, NA Afratis, A Oosterhof, ...
Cellular Signalling 27 (10), 2054-2067, 2015
Targeting the tumor proteasome as a mechanism to control the synthesis and bioactivity of matrix macromolecules
S S Skandalis, A J Aletras, C Gialeli, A D Theocharis, N Afratis, ...
Current molecular medicine 12 (8), 1068-1082, 2012
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance
E Karousou, A Asimakopoulou, L Monti, V Zafeiropoulou, N Afratis, ...
Molecules 19 (6), 7959-7980, 2014
Novel approaches for extracellular matrix targeting in disease treatment
NA Afratis, I Sagi
The Extracellular Matrix: Methods and Protocols, 261-275, 2019
I Sagi, NA Afratis
Springer New York, 2019
The system can't perform the operation now. Try again later.
Articles 1–20